Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125975362 | 12597536 | 2 | F | 20070114 | 20160725 | 20160726 | 20160728 | PER | PHEH2016US018450 | NOVARTIS | 51.92 | YR | M | Y | 0.00000 | 20160728 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125975362 | 12597536 | 1 | PS | NEORAL | CYCLOSPORINE | 1 | Oral | 0.75 ML, (0.5ML IN AM, 0.25ML IN PM) | U | 50716 | .75 | ML | SOLUTION | ||||||
| 125975362 | 12597536 | 2 | SS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | Oral | 360 MG, BID | U | 0 | 360 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125975362 | 12597536 | 1 | Liver transplant |
| 125975362 | 12597536 | 2 | Liver transplant |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125975362 | 12597536 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125975362 | 12597536 | 1 | 20070114 | 0 | ||
| 125975362 | 12597536 | 2 | 20070114 | 0 |